Learn More
Medchemexpress LLC 3-[4-(6-(3-(dimethylamino)propoxy)benzo[d]oxazol-2-yl)phenoxy]-N,N-dimethylpropan-1-amine | 1219962-49-8 | 98.1% | 397.51 g·mol-1 | C23H31N3O3 | 100MG

Supplier: Medchemexpress LLC HY124603100MG
AT791 is a small-molecule inhibitor of Toll-like receptors 7 and 9 (TLR7 and TLR9) described in peer-reviewed literature. It is orally bioavailable, blocks TLR7/9-mediated signaling, and inhibits DNA-TLR9 interaction in vitro, making it useful for preclinical studies of innate immunity and autoimmune disease mechanisms.
- Small-molecule inhibitor of TLR7 and TLR9.
- Orally bioavailable, suitable for in vivo studies.
- Inhibits DNA-TLR9 interaction in vitro.
- Useful for preclinical research on innate immunity and autoimmunity.
- Molecular formula C23H31N3O3; molecular weight 397.51 g·mol-1.
- Typical storage: -20 °C for the powder.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.